Standout Papers

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Nega... 1997 2026 2006 2016 4.4k
  1. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer (2004)
    Soonmyung Paik, Steven Shak et al. New England Journal of Medicine
  2. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study (1998)
    Bernard Fisher, Joseph P. Costantino et al. JNCI Journal of the National Cancer Institute
  3. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer (2006)
    Soonmyung Paik, Gong Tang et al. Journal of Clinical Oncology
  4. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. (1998)
    Bernard Fisher, John Bryant et al. Journal of Clinical Oncology
  5. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. (1997)
    Bernard Fisher, A Brown et al. Journal of Clinical Oncology
  6. A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors (1989)
    B. Fisher, Joe Costantino et al. New England Journal of Medicine
  7. Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer (1995)
    Bernard Fisher, Stewart Anderson et al. New England Journal of Medicine
  8. Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without Radiation (1985)
    Bernard Fisher, Carol Redmond et al. New England Journal of Medicine
  9. Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 * (1994)
    B. Fisher, Joseph P. Costantino et al. JNCI Journal of the National Cancer Institute
  10. Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study (2005)
    Bernard Fisher, Joseph P. Costantino et al. JNCI Journal of the National Cancer Institute
  11. The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 (2003)
    Harry D. Bear, Stewart Anderson et al. Journal of Clinical Oncology
  12. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update (1983)
    Bernard Fisher, Madeline Bauer et al. Cancer
  13. Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 (2006)
    Harry D. Bear, Stewart Anderson et al. Journal of Clinical Oncology
  14. Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer (1993)
    Bernard Fisher, Joseph P. Costantino et al. New England Journal of Medicine
  15. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. (1998)
    Bernard Fisher, James J. Dignam et al. Journal of Clinical Oncology
  16. erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer (1998)
    Soonmyung Paik, John Bryant et al. JNCI Journal of the National Cancer Institute
  17. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. (1993)
    Norman Wolmark, Howard E. Rockette et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 128 standout
Sub-graph 1 of 13

Citing Papers

Deciphering breast cancer: from biology to the clinic
2023 Standout
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
2023 StandoutNature
14 intermediate papers

Works of D. Lawrence Wickerham being referenced

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
and 10 more

Author Peers

Author Last Decade Papers Cites
D. Lawrence Wickerham 19757 16864 8913 126 32.3k
Carol Redmond 13893 12799 6532 145 26.0k
Joseph P. Costantino 12065 11119 8024 200 23.7k
Aron Goldhirsch 16911 20081 5965 488 32.8k
Aman U. Buzdar 20608 23340 8690 505 38.6k
Umberto Veronesi 20996 12099 4436 402 31.3k
Alan S. Coates 11056 14199 4826 297 23.4k
Clifford A. Hudis 13808 23054 5748 509 38.8k
Richard G. Margolese 17459 11537 3272 97 24.0k
Gary M. Clark 14287 27959 5781 265 43.7k
Stephen B. Edge 10648 13138 2100 260 27.7k

All Works

Loading papers...

Rankless by CCL
2026